G01N 2333/96452
Factor xi
Official title: Factor XI (3.4.21.27)
G01N2333/96452 (Factor xi) appears on 7 US grants and 10 published applications in this corpus.
Search patents in G01N- Granted patents
- 7
- Published applications
- 10
- Assignees
- 15
- Inventors
- 35
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heparin-insensitive assay for factor XIa25 Aug 2026US 12,716,084 B2Takeda Pharmaceutical Company Limited
- Anti-FXI/FXIa antibody and use thereof25 Mar 2025US 12,258,419 B2Klus Pharma Inc.
- Method for evaluating blood coagulation reaction3 Aug 2021US 11,078,518 B2Chugai Seiyaku Kabushiki Kaisha
- Factor XIa-specific aptamers3 Dec 2019US 10,494,634 B2Canadian Blood Services
- Factor IX chromogenic assay6 May 1997US 5,627,038 ADade International Inc.
- Methods and devices for detection of coagulation impairment3 Sep 2026US 2026/0259231 A1Coagulo Medical Technologies, Inc.
- Method for excluding factor xia inhibitors in patient samples5 Mar 2026US 2026/0063650 A1Siemens Healthcare Diagnostics Products GmbH
- Compounds for the detection and inhibition of coagulation proteases26 Jun 2025US 2025/0208137 A1Cambridge Enterprise Limited
- Methods for the detection of anti-drug antibodies against factor xi and/or factor xia antibodies7 Mar 2024US 2024/0077497 A1Anthos Therapeutics, Inc.
- Blood coagulation test reagent, and blood coagulation test method5 Oct 2023US 2023/0314454 A1Thrombo Translational Research Lab Inc.
Most cited
By later US patents
- High molecular weight kininogen assay11US 4,882,272 ATemple University of the Commonwealth System of Higher Education · 1989
- Peptide derivative7US 4,257,939 AAjinomoto Co., Inc. · 1981
- Factor IX chromogenic assay5US 5,627,038 ADade International Inc. · 1997
- Factor XIa-specific aptamers1US 10,494,634 B2Canadian Blood Services · 2019